{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:06:49Z","timestamp":1760731609515,"version":"3.41.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>World Health Organization (WHO) grade III anaplastic meningioma is scarce. In this way, most studies compared WHO grade I and II. Otherwise, some authors are uncertain about using <jats:sup>18<\/jats:sup>F-FDG as a diagnostic tool to estimate the WHO grade, especially high. We report the case from a man with a grading tumor evolution from WHO grade II atypical to grade III anaplastic metastatic meningioma. This turning point was imaged using <jats:sup>68<\/jats:sup>Ga-DOTATOC and <jats:sup>18<\/jats:sup>F-FDG. Diagnostic was confirmed by histology. The case underlines the unparalleled power of molecular imaging characterized by high sensitivity staging and spectacular avidity changing relationship with grading tumor evolution.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004985","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T14:00:09Z","timestamp":1703340009000},"page":"175-176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Transformation From Atypical to Anaplastic Metastatic Meningioma"],"prefix":"10.1097","volume":"49","author":[{"given":"Robin","family":"Morcet-Delattre","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, Eug\u00e8ne Marquis Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Meneret","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Eug\u00e8ne Marquis Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Coue","sequence":"additional","affiliation":[{"name":"Anatomopathology Department, Ouest Pathologie Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Vauleon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Prigent","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Eug\u00e8ne Marquis Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","year":"2021","journal-title":"Neuro Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/neuonc\/nox112","article-title":"PET imaging in patients with meningioma-report of the RANO\/PET group","volume":"19","year":"2017","journal-title":"Neuro Oncol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/RLU.0000000000004518","article-title":"68Ga-DOTATOC PET in extracranial hepatic and bone metastasis of atypical refractory meningioma: a case report","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-013-1074-x","article-title":"Distant metastases in meningioma: an underestimated problem","volume":"112","year":"2013","journal-title":"J Neurooncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00259-009-1133-x","article-title":"18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma","volume":"36","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2967\/jnumed.120.249607","article-title":"Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: individual patient data meta-analysis","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00259-022-06044-9","article-title":"Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250621","first-page":"1538","article-title":"Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE\/-TOC uptake","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/neuonc\/now001","article-title":"68Gallium-DOTATATE PET in meningioma: a reliable predictor of tumor growth rate?","volume":"18","year":"2016","journal-title":"Neuro Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:03:06Z","timestamp":1750532586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004985"}},"subtitle":["Evolutionary Turning Point Marked by Strong 18F-FDG Avidity and Uptake Collapse From 68GA-DOTATOC"],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004985","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,12,23]]}}}